Azurity Pharmaceuticals: Anemia, Iron-Deficiency trials

The registry lists 11 Anemia, Iron-Deficiency studies with Azurity Pharmaceuticals as lead sponsor. 2 are open to participants now and 9 have results posted.

Phase 2 1Phase 3 9Phase 4 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric SubjectsRecruitingNCT03893045Phase 3
• A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)RecruitingNCT03619850Phase 3
• A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)CompletedNCT02694978Phase 3Results posted
• A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney DiseaseTerminatedNCT01264679Phase 3Results posted
• Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on HemodialysisCompletedNCT01227616Phase 4Results posted
• A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney DiseaseTerminatedNCT01155388Phase 3Results posted
• A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney DiseaseTerminatedNCT01155375Phase 3Results posted
• A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency AnemiaCompletedNCT01114217Phase 3Results posted
• A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency AnemiaCompletedNCT01114204Phase 3Results posted
• A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency AnemiaCompletedNCT01114139Phase 3Results posted
• A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney DiseaseCompletedNCT01052779Phase 2Results posted